# A Study Comparing a Pre-filled Safety Syringe and an Autoinjector for SHR-1703 Injection in Healthy Participants

> **NCT07701239** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Guangdong Hengrui Pharmaceutical Co., Ltd** · enrollment: 84 (estimated)

## Conditions studied

- Asthma With Eosinophilic Phenotype

## Interventions

- **DRUG:** SHR-1703 Injection
- **DRUG:** SHR-1703 Injection

## Key facts

- **NCT ID:** NCT07701239
- **Lead sponsor:** Guangdong Hengrui Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2027-04
- **Final completion:** 2027-04
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2026-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07701239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07701239, "A Study Comparing a Pre-filled Safety Syringe and an Autoinjector for SHR-1703 Injection in Healthy Participants". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07701239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*